Archive for the ‘Lyme’ Category

EBV & Lyme: A Patient’s Perspective

https://www.globallymealliance.org/blog/epstein-barr-virus-and-lyme-disease?

Understand the intricate relationship between Epstein-Barr Virus (EBV) and Lyme Disease through the experience of Jennifer Crystal. Learn how they coexist and impact each other in chronic illness.

Whenever I write about my chronic tick-borne illnesses Lyme disease and babesiosis, I always add “as well as chronic active Epstein-Barr virus (EBV).” This is because for me—and for many Lyme disease patients—EBV and Lyme go hand in hand. Though one is a virus and one is a bacterial infection, the two wreak havoc on the body together, and a flare of one can lead to a flare of another.

I know this now, two decades into my chronic illness journey. When I got mononucleosis, which is caused by the Epstein-Barr virus, in 2003, I had no idea that I also had underlying tick-borne infections or that the two could impact each other. Since 1997, I’d had all sorts of strange symptoms, ranging from an on-and-off-again flu to migraine headacheshypoglycemia, asthma, trembling hands, and hives. Each of these complaints had been treated individually—often brushed aside as stress or “just feeling run down”—and tick-borne illnesses were never considered. Ironically, every time the flu-like symptoms came back, I would worry that I had mono. I knew that virus could take a while to get over, and I didn’t have time to be sick. But the tests were always negative.

Until, days before I was to start a job as a Head Counselor at a summer camp in Maine, a sore throat and mounting fatigue led to a mono test that actually did come back positive. Now I really didn’t have time to be sick. I had just finished a strenuous year teaching high school English and Journalism in Colorado, had driven cross country by myself, and was supposed to spend only a few days with family in Connecticut before heading off to Maine.

The universe had other plans, but I didn’t agree with them. I knew that some people got over mono in a few weeks, while some cases took longer. I took a steroid to alleviate symptoms and speed up recovery. I rested in Connecticut for two weeks. And then, with my doctor’s permission, I set off for camp, where I so desperately wanted to be.

Camp needed me, too, as the oldest returning Head Counselor. But my being there that summer wasn’t fair to anyone—not to the campers, not to the directors, not to me. Camp needed me to give my all. I could for a short while, but then the fatigue of mono came raring back, and I found myself dragging my body to activities.

By the end of the summer, I was bedridden. By fall, I was no better. I slept twenty hours a day and developed new symptoms like burning extremities and hallucinogenic nightmares. Tests for mono remained positive, and tests for Epstein-Barr titers remained high. My doctor explained to me that people who have had mono will always test positive for Epstein-Barr virus, but that once the mono goes away, the Epstein-Barr virus titers should decrease (the same way those of us who had chicken pox as kids always carry that virus even though it’s not active). In my case, the titers remained high, which is known as chronic active Epstein-Barr virus, or chronic mono. The doctor told me it might take a couple years for me to get better.

I was devastated. I was supposed to work as a ski instructor in the Rocky Mountains that winter. That dream was shattered. Unable to support or care for myself, I had to surrender my independence and move back with my parents in Connecticut.

I blamed myself for the chronic active Epstein-Barr virus because I’d pushed my body to go to camp. While that choice probably didn’t help my recovery, there were much larger, physiological explanations for my immune system’s inability to fight off mono: Lyme disease, babesiosis, and ehrlichiosis, which my body had been harboring since an unknown tick bite while at camp in 1997.

For the first two years that I had chronic active EBV, I spent so much energy trying to convince people that I really was sick, not lazy; that EBV was a legitimate diagnosis; and that I wanted to be working, socializing, and exercising as I once had, but could barely move from bed—that I didn’t consider whether anything else might be going on in addition to EBV, rather than instead of it.

One day in 2005 while drying my hair, I noticed circular rashes on my elbows when I saw my raised arms in the mirror. I’d become so accustomed to writing symptoms off as nothing, but the naturopathic physician who’d been treating me for EBV said, “Those look suspiciously like the bullseye rashes of Lyme disease,” which he explained can show up months or years after a tick bite, in various places on the body. He said, “I’ve started to suspect you have something additional going on, like an underlying infection, because otherwise you would be getting better.” He sent me to a Lyme Literate Medical Doctor (LLMD) who ran tests that showed I indeed had three tick-borne diseases. The doctor traced these illnesses back to a red rash I’d had on my arm in 1997, just before all my symptoms began. He concluded that the tick-borne diseases had come out in full force when I got mono, because my immune system was so overtaxed that it couldn’t fight all the illnesses; instead, it was walloped by them.

Once I was adequately treated for tick-borne illness, my EBV symptoms quieted, but they still flare from time to time. Because Lyme and EBV symptoms can be so similar (flu-like symptoms, fatigue, achiness, low grade fever), sometimes it’s hard for me to tell which one is activated. Having spent so long in the throes of tick-borne disease treatment and recovery, I sometimes forget that I have EBV, too. But when symptoms flare, it’s important for me to take a step back and ask, is this Lyme, or could this be EBV? Sometimes it’s both and a slight change in a supplement can help either. Sometimes it’s EBV and I need to rest. Sometimes it’s babesiosis and I need a specific anti-malarial medication.

Scientists don’t yet know why there seems to be such a correlation between Lyme and EBV, though they have discovered EBV may be a leading cause of Multiple Sclerosis[i], a Lyme imitator. We know from emerging science and from patient experience that EBV seems to impact certain autoimmune disorders and infections, and vice-versa. Until the science catches up to the experience, the important thing is for patients with overlapping symptoms to keep both EBV and other medical conditions like Lyme disease in mind. If they’ve only been diagnosed with one, they may only be fighting half the battle.

[i] https://www.nih.gov/news-events/nih-research-matters/study-suggests-epstein-barr-virus-may-cause-multiple-sclerosis

Writer

Jennifer Crystal

Opinions expressed by contributors are their own. Jennifer Crystal is a writer and educator in Boston. Her work has appeared in local and national publications including Harvard Health Publishing and The Boston Globe. As a GLA columnist for over six years, her work on GLA.org has received mention in publications such as The New Yorker, weatherchannel.com, CQ Researcher, and ProHealth.com. Jennifer is a patient advocate who has dealt with chronic illness, including Lyme and other tick-borne infections. Her memoir, One Tick Stopped the Clock, is forthcoming from Legacy Book Press in September 2024. Ten percent of proceeds from the book will go to Global Lyme Alliance. Contact her via email below.

Email: lymewarriorjennifercrystal@gmail.com

Rejuvenate Cells & Combat Chronic Illness With a Fasting Mimicking Diet

https://www.treatlyme.net/guide/fasting-mimicking-diet

Rejuvenate Your Cells and Combat Chronic Illness with a Fasting Mimicking Diet

By Dr. Marty Ross

Sept. 2024

If you’re grappling with chronic Lyme disease, Bartonella, Babesia, or mold toxicity, the term “fasting” may seem hard to think about. However, the Fasting Mimicking Diet (FMD) offers a scientifically backed, less intense method that promises significant health benefits. Imagine rejuvenating your injured cells and potentially alleviating symptoms without the extreme measures associated with traditional fasting.

Interested? Let’s explore how FMD may be the game-changer you need.

What is the Fasting Mimicking Diet?

The Fasting Mimicking Diet is a revolutionary dietary protocol that mimics the effects of fasting while still allowing some nutrient intake. Developed by Dr. Valter Longo and his team at the University of Southern California, this diet aims to provide the health benefits of fasting without the hardship of complete food deprivation. It’s a five-day plan that involves reduced calorie intake, typically between 750 to 1,100 calories per day, mainly from plant-based foods, while ensuring that your body enters a fasting-like state.

Understanding Cellular Rejuvenation

Cellular rejuvenation refers to the process of renewing old or damaged cells. This concept is critical for those with chronic illnesses like Lyme disease, Bartonella, Babesia, and mold toxicity, where cellular damage and inflammation from oxidation damage could lead to ongoing symptoms. FMD has been shown to trigger autophagy, a crucial cellular cleanup process where the body removes damaged cells and regenerates new ones. This process not only helps in maintaining cellular health but also stimulates the production of stem cells, which are essential for repairing and regenerating tissues and can help remove senescent zombie cells. By doing so, FMD promotes cellular regeneration and can lead to improved overall health for people living with chronic tick-borne infections and mold toxicity. FMD also potentially enhances longevity and reduces the risk of various age-related diseases.

Key Health Enhancing and Anti-Aging Pathways Affected by the Fasting Mimicking Diet

  • Autophagy Pathway: FMD induces autophagy, a critical process for cellular cleanup and renewal. This promotes the removal of damaged proteins and organelles, supporting longevity and overall health, and may help reduce cellular debris linked to chronic infections like tick-borne diseases and mold toxicity.
  • Cellular Senescence: FMD aids in addressing cellular senescence, where cells lose their ability to divide and function optimally while often developing a pro-inflammatory secretory profile known as the Senescence-Associated Secretory Phenotype (SASP). Chronic infections are a cause of early cellular senescence. By removing these senescent cells and fixing the effects of SASP, the diet may reduce inflammation and tissue damage, contributing to healthier aging, an extended lifespan, and improved health for people with chronic infections and mold-related issues.
  • Improvements in Immune Function: FMD enhances immune function by promoting the regeneration of immune cells and supporting a balanced immune response. This can lead to a more robust defense against infections and a reduction in inflammation, benefiting individuals with chronic illnesses such as tick-borne diseases and mold toxicity. Enhanced immune function contributes to healthier aging and improved resilience against stressors, ensuring better overall health and longevity.
  • mTOR (Mechanistic Target of Rapamycin): FMD reduces signaling through the mTOR pathway, which is closely linked with cell growth, aging, and immune function. Inhibiting mTOR activity can enhance cellular stress resistance, longevity, and may aid in managing chronic infections by improving immune response.
  • IGF-1 (Insulin-like Growth Factor 1): FMD lowers levels of IGF-1, a hormone that promotes growth and has been associated with aging and cancer. Reducing IGF-1 can lead to decreased cellular proliferation and increased autophagy, which may benefit those dealing with persistent infections and inflammation.
  • AMPK (AMP-Activated Protein Kinase): By activating AMPK, the diet enhances energy metabolism and promotes the breakdown of fats. This pathway is associated with improved longevity, protection against age-related diseases, and could also support detoxification and energy balance in individuals facing mold toxicity and chronic infections.
  • Sirtuins Activation: The diet stimulates sirtuins, a family of proteins that regulate cellular health and longevity. Activation of sirtuins is linked to improved DNA repair, enhanced stress resistance, and extended lifespan; these functions may also aid individuals with chronic tick-borne infections and mold toxicity by bolstering cellular resilience and repair mechanisms.  (See link for article)

________________

For more:

IGeneX Lyme ImmunoBlot Test Receives FDA Clearance

https://www.lymedisease.org/lyme-immunoblot-fda-clearance/

IGeneX Lyme ImmunoBlot test receives FDA clearance

The Lyme ImmunoBlot test first introduced by IGeneX in 2017 has now been converted to a test kit–and has received FDA clearance.

The name of the test is iDart™ Lyme IgG ImmunoBlot Kit.

It’s a stand-alone test for the detection of IgG antibodies against Borrelia-causing Lyme disease.

The iDart ImmunoBlot Kit features 31 Lyme antigen bands, which are more antigen bands than any other Lyme immunoblot test on the market.

Moreover, it is the only immunoblot that includes Osp A (P31) and Osp B (P34). (Note: those are the two bands removed from other Lyme tests in the 1990s because of their use in the development of Lyme vaccines.)

The inclusion of 31 antigens improves the sensitivity of the detection of Lyme-specific IgG antibodies, which in turn will improve the sensitivity of the diagnosis of Lyme disease in suspected patients without sacrificing specificity.

“We are delighted to have received FDA clearance for our Lyme ImmunoBlot Kit,” said Dr. Jyotsna Shah, Ph.D., President and Director of IGeneX Labs.

These kits are not available for sale to consumers, but only to labs who perform Lyme diagnostic testing.

Key features of the iDart Lyme IgG ImmunoBlot kit

  • Results interpretation is based upon new criteria and not CDC criteria.
  • The bands are grouped according to their antigen groups. The test is considered positive if the Lyme Screen Antigen (LSA) band and one or more bands from at least two other groups are present on the ImmunoBlot.
  • Bands 31 and 34 are included, making this the only FDA-cleared Lyme serological test that includes these bands.

SOURCE: IGeneX, Inc.

Medicine Struggles to Define Chronic Lyme. Long Covid Has Only Made it Harder

https://www.statnews.com/2024/09/09/lyme-disease-long-covid-symptoms-diagnosis-research/

Medicine struggles to define chronic Lyme. Long Covid has only made it harder

By Isabella Cueto and Alina Sajani

Sept. 9, 2024

Going to the doctor is already tricky enough for people with chronic symptoms of Lyme disease. Their concerns often dismissed by mainstream medicine, those patients now face an additional hurdle: ruling out long Covid.

The two illnesses — one seeping in over the course of decades and another suddenly springing to life on a massive scale — share many qualities, including being widely misunderstood. But as efforts to demystify long Covid intensify, so does interest in studying neglected conditions, including persistent complications from Lyme disease.

Long Covid was a crash course in chronic conditions that start with infection. “As a result, Lyme patients are now met with more compassion and understanding than ever in the past. It is now harder for a physician to dismiss the possibility of a Lyme diagnosis out of hand than it was before the pandemic,” said Bernadette Clavier, facilitator of the Coalition for Infection-Associated Chronic Conditions and Illnesses Research.

New studies aim to tease apart the diseases’ differences and similarities in hopes of finding treatments for patients that have gone without vetted, tailored therapeutics, in some cases for decades. (See link for article)

_______________

**Comment**

The article discusses the case of a Lyme advocate who had a mild case of COVID and only lost her sense of taste and smell, but who crashed two months later.  Joint pain and GI issues popped up seemingly out of nowhere.  She also got severe brain fog.

I’m sure this patient isn’t alone.

COVID did a number on both of us as well and we were very sick, numerous times.  The first time caused us to relapse with Bartonella.

But this patient is blaming COVID for it all.  I question the logic of this as there is no accurate test to prove it. One of the most common features of long-COVID syndrome is post-exertional malaise and research has shown the spike protein exhausts cardiomyocyte mitochondria.  Also, ‘Long COVID’ symptoms mirror those in other viral illnesses and with Lyme/MSIDS it is nearly impossible to discern what is causing what.  I can rattle off 10 things that cause joint pain, GI issues, and brain fog, including a bevy of bacterial and parasitic infections!

Researchers at Johns Hopkins and other institutions have a lost of potential new therapies they’d like to study – everything from inflammatory treatments to antibiotic combination therapies, brain stimulation, and magic mushrooms.

It is widely known that ALL vaccines prime illness by injecting foreign proteins and the COVID shots specifically cause T-cell exhaustion and masks are immunosuppressive These issues are side-stepped regarding ‘long covid.’ A top biologist states they are ‘bioweapons’ that can target entire populations by ‘triggering the immune system to stand down.’  This is the last thing a Lyme/MSIDS patient needs!

Italian scientists have issued a disturbing warning over a new neurological emergency surging in those who received the mRNA shots and others have shown they have caused excess death, organ damage, autoimmunity, and myocarditis and pericarditis, and urinary and bladder issues.  Then there’s the paper showing the spike protein induces a lethal cancer phenotype.

Seems to me ‘Long COVID’ is an easy scapegoat from much larger and damning issues.

Two Plants in Plaintain Family Show Antioxidant and Bb Inhibiting Properties

https://www.mdpi.com/1422-0067/25/13/7112

Plantago major and Plantago lanceolata Exhibit Antioxidant and Borrelia burgdorferi Inhibiting Activities

by Pille-Riin Laanet, Olga Bragina, Piia Jõul and Merike Vahe*
Department of Chemistry and Biotechnology, Tallinn University of Technology, Akadeemia tee 15, 12618 Tallinn, Estonia
*Author to whom correspondence should be addressed.
Int. J. Mol. Sci. 202425(13), 7112; https://doi.org/10.3390/ijms25137112
Submission received: 18 May 2024 / Revised: 15 June 2024 / Accepted: 20 June 2024 / Published: 28 June 2024

Abstract

Lyme disease, caused by Borrelia burgdorferi sensu lato infection, is the most widespread vector-borne illness in the Northern Hemisphere. Unfortunately, using targeted antibiotic therapy is often an ineffective cure. The antibiotic resistance and recurring symptoms of Lyme disease are associated with the formation of biofilm-like aggregates of B. burgdorferi. Plant extracts could provide an effective alternative solution as many of them exhibit antibacterial or biofilm inhibiting activities. This study demonstrates the therapeutic potential of Plantago major and Plantago lanceolata as B. burgdorferi inhibitors. Hydroalcoholic extracts from three different samples of each plant were first characterised based on their total concentrations of polyphenolics, flavonoids, iridoids, and antioxidant capacity. Both plants contained substantial amounts of named phytochemicals and showed considerable antioxidant properties. The major non-volatile constituents were then quantified using HPLC-DAD-MS analyses, and volatile constituents were quantified using HS-SPME-GC-MS. The most prevalent non-volatiles were found to be plantamajoside and acteoside, and the most prevalent volatiles were β-caryophyllene, D-limonene, and α-caryophyllene. The B. burgdorferi inhibiting activity of the extracts was tested on stationary-phase B. burgdorferi culture and its biofilm fraction. All extracts showed antibacterial activity, with the most effective lowering the residual bacterial viability down to 15%. Moreover, the extracts prepared from the leaves of each plant additionally demonstrated biofilm inhibiting properties, reducing its formation by 30%.
_______________
**Comment**
Both plants are in the plantain family, which is a diverse family of flowering plants and herbs and includes snapdragons, foxglove, particularly the broadleaf or greater plaintain (Plantago major) which is considered an herb, and narrowleaf plantain or ribwort (Plantago lanceolata).  You will find the former to be a common weed that is often found along the edge of the road.  This is handy because if you react to bee/wasp stings you can chew these leaves which are highly anti-inflammatory and them put it directly on the sting until you get home.  I’ve had to do this.  The tea is also excellent for bronchitis.  While narrowleaf plantain is has supposedly been introduced in WI, I don’t believe I’ve ever seen it and I consider myself a plant freak.
For more:

Word of warning: many think herbs are always safe.  I know of patients who messed themselves up pretty badly with herbs.  Herbs are strong medicine.  Never forget that.  For some they make all the difference.  For others, not so much.  Make sure you learn all you can about these powerful plants and as always – use with caution – as with any treatment.  I’m certainly not trying to dissuade you, just remind you to take heed, do your homework, and preferably work with experienced herbalists.  Nothing beats experience.